STOCK TITAN

First Trust entities jointly hold 3.02M shares of abrdn Life Sciences Investors (HQL)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

abrdn Life Sciences Investors disclosure: a Schedule 13G/A shows First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation jointly report beneficial ownership of 3,021,786 shares of Common stock, representing 10.09% as of 02/28/2026.

The filing states the three entities are filing jointly under Rule 13d-1(k)(1), describes relationships among the entities, and includes disclaimers that they disclaim beneficial ownership of the shares held in certain unit investment trusts and advisory accounts.

Positive

  • None.

Negative

  • None.

Insights

First Trust group reports a >10% stake and files jointly under 13d-1(k)(1).

The filing lists 3,021,786 shares and 10.09% beneficial ownership as of 02/28/2026, and explains that unit investment trusts and advisory relationships account for holdings. The Charger Corporation is identified as general partner.

Governance implications depend on trustee voting rules and advisory agreements; the filing also contains a formal disclaimer of beneficial ownership for certain trust-held shares. Subsequent filings would clarify any changes in voting or disposition powers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does First Trust report in abrdn Life Sciences Investors (HQL)?

First Trust reports beneficial ownership of 3,021,786 shares, representing 10.09% of Common stock as of 02/28/2026. The amount is reported jointly by three affiliated entities under Rule 13d-1(k)(1).

Do the filers claim voting or dispositive power over the HQL shares?

The filing reports 0 sole voting power and 57,337 shared voting power, with 3,021,786 shared dispositive power. It also states trustees vote unit trust shares and the filers disclaim beneficial ownership of certain trust‑held shares.

Does this Schedule 13G/A indicate active control or a passive investment?

The joint filing under Rule 13d-1(k)(1) typically indicates passive intent; the filing describes advisory and trustee voting arrangements and includes a disclaimer of beneficial ownership for trust‑held shares, rather than asserting direct control.





02/28/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



First Trust Portfolios L.P.
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer
Date:03/06/2026
First Trust Advisors L.P.
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer
Date:03/06/2026
The Charger Corporation
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer and Treasurer
Date:03/06/2026
Exhibit Information

Please see Exhibit 99.1 for Joint Filing Agreement